• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Short-term hypofractionated radiotherapy followed by total mesorectal excision].

作者信息

Lammering G, Hartmann K A, Frenken M, Aryus B, Döker R, Ulrich B

机构信息

Klinik für Strahlentherapie und Radioonkologie, Heinrich-Heine-Universität Düsseldorf.

出版信息

Strahlenther Onkol. 2000 Dec;176(12):555-9. doi: 10.1007/pl00002324.

DOI:10.1007/pl00002324
PMID:11140149
Abstract

PURPOSE

Is preoperative short-term radiotherapy of operable rectal carcinoma feasible with regard to early side effects and perioperative complications?

PATIENTS AND METHODS

As of December 1996 to March 1999, 34 patients with locally advanced rectal cancer have been irradiated preoperatively with 5 times 5 Gy. After CT-planning, radiotherapy was administered using a 3-field or 4-field box technique with 2 anterior-posterior fields or a posterior field of 9 +/- 2 cm x 11.5 +/- 2.4 cm and 2 opposed bilateral fields of 9 +/- 1.5 cm x 11.5 +/- 2 cm with 6- to 25-MV photons. Surgery was performed 14 +/- 6 days after irradiation in 33/34 patients (82% anterior resection with total mesorectal excision, 18% abdomino-perineal resection). Patients with a positive lymph node status or pT3/4 lesions underwent adjuvant chemotherapy with 5-Fluorouracil (5-FU). The median follow-up period is 189 days (range: 15 to 548 days).

RESULTS

The following early side reactions were registered: increased bowel movements (4/34), fatigue (2/34), pain in the groins (1/34), nausea and perianal smart (1/34), vertigo (1/34), temporary urinary obstruction (1/34). One patient with heart failure NYHA Grade III died of a heart attack after 21 days. Preoperative T and N categories showed a distribution of 3, 29 and 2 for T4, T3 and unknown and 20, 11 and 3 for N+, N- and unknown; postoperative T and N categories showed a distribution of 3, 19 and 11 for T4, T3 and T2 and 19 and 14 for N+ and N-. In 32 of 33 patients tumor-free margins were achieved. One patient with peritoneal metastases had a R1 resection. In 3 patients metastases were detected intraoperatively. Perioperative complications were: 2 cases of leaking anastomosis and postoperative bowel atonia, 1 case with bowel obstruction, delayed wound healing, wound dehiscence and temporary renal dysfunction.

CONCLUSION

Preoperative radiotherapy is feasible with moderate toxicity and is able to induce down staging despite the short time interval between radiotherapy and surgery.

摘要

相似文献

1
[Short-term hypofractionated radiotherapy followed by total mesorectal excision].
Strahlenther Onkol. 2000 Dec;176(12):555-9. doi: 10.1007/pl00002324.
2
Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.部分T3期直肠癌患者术前放化疗后采用局部切除的长期结果。
Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1098-105. doi: 10.1016/j.ijrobp.2004.04.062.
3
Pre-operative chemoradiotherapy in locally advanced rectal cancer.局部晚期直肠癌的术前放化疗
Aust N Z J Surg. 1999 Oct;69(10):737-42. doi: 10.1046/j.1440-1622.1999.01677.x.
4
Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.术前超分割放化疗用于既往盆腔放疗后的局部复发性直肠癌患者:一项多中心II期研究。
Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. doi: 10.1016/j.ijrobp.2005.09.017. Epub 2006 Jan 18.
5
Phase I dose escalating trial of hyperfractionated pre-operative chemoradiation for locally advanced rectal cancer.局部晚期直肠癌术前超分割放化疗的I期剂量递增试验。
Int J Radiat Oncol Biol Phys. 1998 Aug 1;42(1):43-50. doi: 10.1016/s0360-3016(98)00172-2.
6
A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma.一项针对局部晚期直肠癌的三维计划同步加量放疗与5-氟尿嘧啶化疗持续静脉输注的I/II期试验。
Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1299-308. doi: 10.1016/s0360-3016(01)01540-1.
7
Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial.新辅助卡培他滨联合标准放疗用于局部晚期直肠癌患者:一项II期试验的成熟结果
Strahlenther Onkol. 2008 Sep;184(9):450-6. doi: 10.1007/s00066-008-1751-4. Epub 2008 Sep 19.
8
Phase II clinical trial of preoperative combined chemoradiation for T3 and T4 resectable rectal cancer: preliminary results.T3和T4期可切除直肠癌术前同步放化疗的II期临床试验:初步结果
Dis Colon Rectum. 2001 Aug;44(8):1113-22. doi: 10.1007/BF02234631.
9
[Preoperative diagnostic procedures in locally advanced rectal carcinoma (> or =T3 or N+). What does endoluminal ultrasound achieve at staging and restaging (after neoadjuvant radiochemotherapy) in contrast to computed tomography?].[局部进展期直肠癌(≥T3 或 N+)的术前诊断程序。与计算机断层扫描相比,腔内超声在分期及新辅助放化疗后的再分期中能达到什么效果?]
Chirurg. 2003 Mar;74(3):224-34. doi: 10.1007/s00104-002-0609-z.
10
Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer.术前同步推量放疗联合持续输注5-氟尿嘧啶治疗局部晚期直肠癌的前瞻性试验
Int J Radiat Oncol Biol Phys. 2000 Jun 1;47(3):713-8. doi: 10.1016/s0360-3016(00)00418-1.